MYELOID MALIGNANCIES
Clinical trials for MYELOID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCIES trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for elderly blood cancer patients: major trial tests drug to make transplants more effective
Disease control Recruiting nowThis study is for people over 50 with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are getting a stem cell transplant. It compares two different drug combinations used to prepare the body for the transplant. The goal is to see if adding a drug called venetoc…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test supercharged immune cells to fight tough blood cancers
Disease control Recruiting nowThis study is testing a new cell therapy for adults whose blood cancers have returned or not responded to other treatments. Doctors will give patients specially engineered immune cells from donated cord blood, aiming to find a safe and effective dose. The goal is to see if this a…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope to keep blood cancer at bay after transplant
Disease control Recruiting nowThis study is testing whether a drug called olutasidenib is safe and can help prevent cancer from returning in patients who have a specific genetic change (IDH1 mutation) in their blood cancer and have recently received a stem cell transplant. The drug is taken as a pill for up t…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test 'Supercharged' immune cells against tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for adults with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that has come back or hasn't responded to other treatments. Doctors are giving patients specially engineered immune cells (called PRAME-TCR-NK cell…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope to stop Cancer's return after transplant
Disease control Recruiting nowThis study is testing whether a two-drug treatment given after a bone marrow transplant can help prevent leukemia and related blood cancers from coming back. It involves children and young adults up to age 39 who have had a transplant for conditions like acute myeloid leukemia (A…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC